TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8285592

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy in symptomatic patients with greater than 70% stenosis (NASCET, ECST)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy in asymptomatic patients (Mayo asymptomatic trial, Carotid Artery Stenosis with Asymptomatic Narrowing: Operation Versus Aspirin trial, VA Asymptomatic Trial)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (asymptomatic patients)
Number of subjects: 0
Study: 3605164

Group type: EXPERIMENTAL
Intervention: Checklist intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: No checklist intervention (Control)
Number of subjects: 200
Study: 29473908

Group type: EXPERIMENTAL
Intervention: l-carnitine-l-tartrate 1500 mg per day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (isonitrogenous)
Number of subjects: 0
Study: 27328737

Group type: COMPARATOR
Intervention: Dexamethasone 0.15 mg·kg(‐1) IV plus sham acupuncture
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Acupuncture at P6 bilaterally and CV13 plus 2 ml of normal saline IV
Number of subjects: 120

Group type: COMPARATOR
Intervention: Dexamethasone group
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Acupuncture group
Number of subjects: 120
Study: 25796362

Group type: EXPERIMENTAL
Intervention: CTC (Computed Tomographic Colonography)
Number of subjects: 5384

Group type: COMPARATOR
Intervention: Barium enema
Number of subjects: 5384

Group type: COMPARATOR
Intervention: Colonoscopy
Number of subjects: 5384

Group type: EXPERIMENTAL
Intervention: CTC
Number of subjects: 5384
Study: 23780705

Group type: EXPERIMENTAL
Intervention: Initial lapse context (talking with friends, angry)
Number of subjects: 551

Group type: EXPERIMENTAL
Intervention: Initial lapse context (social)
Number of subjects: 551

Group type: EXPERIMENTAL
Intervention: Initial lapse context (alone)
Number of subjects: 551

Group type: EXPERIMENTAL
Intervention: Initial lapse context (with spouse, angry)
Number of subjects: 551

Group type: EXPERIMENTAL
Intervention: Initial lapse context (with smoking spouse)
Number of subjects: 551
Study: 20959067

Group type: EXPERIMENTAL
Intervention: Serum ICTP
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Serum BAP
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Joint detection of ICTP and BAP
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Serum BAP in patients with multiple B.M (lesions>=3)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Serum BAP in patients with mixed pattern
Number of subjects: 110
Study: 18371470

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents
Number of subjects: 2951

Group type: COMPARATOR
Intervention: Bare-metal stents
Number of subjects: 2951
Study: 16162714

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 14513588

Group type: EXPERIMENTAL
Intervention: Topical application of immunoglobulin yolk antibodies (IgY) spray (n = 9)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 0.15% chlorhexidine (CH) spray (positive control group, n = 9)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo phosphate buffered saline (PBS) spray (negative control group, n = 6)
Number of subjects: 24
Study: 10526263

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy with cisplatin (200 mg) and epirubicin (120 mg) via the external carotid artery
Number of subjects: 131

Group type: COMPARATOR
Intervention: Preoperative radiation therapy (46 grays)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Postoperative quality of life
Number of subjects: 131
Study: 8722937

Group type: EXPERIMENTAL
Intervention: Oral vancomycin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral teicoplanin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral fusidic acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral metronidazole
Number of subjects: 0
Study: 1841548

Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 7048923

Group type: EXPERIMENTAL
Intervention: Intravenous acyclovir
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 30636072

Group type: EXPERIMENTAL
Intervention: 1-(2-hydroxyethyl)-2-imidazolidinone (HEI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control without HEI
Number of subjects: 0
Study: 29873727

Group type: EXPERIMENTAL
Intervention: Zilpaterol hydrochloride (ZH) supplementation (90 mg.d‐1 per steer for 20 d)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Zilpaterol hydrochloride (ZH) supplementation
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Maintenance energy intake (MA)
Number of subjects: 56
Study: 26890767

Group type: EXPERIMENTAL
Intervention: Standardized computer-assisted needs assessment
Number of subjects: 227
Study: 25266518

Group type: EXPERIMENTAL
Intervention: Sleep Deprivation (SD) for 36 hours
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sleep Deprivation (SD)
Number of subjects: 18
Study: 21918977

Group type: EXPERIMENTAL
Intervention: Preoperative serum CA-125 levels above 30 U/ml
Number of subjects: 657
Study: 20113825

Group type: EXPERIMENTAL
Intervention: Trastuzumab (1 year of treatment, given as neoadjuvant and adjuvant treatment)
Number of subjects: 235

Group type: COMPARATOR
Intervention: No trastuzumab (control group)
Number of subjects: 235
Study: 17331803

Group type: EXPERIMENTAL
Intervention: Weight loss group (10% weight loss requirement)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Non-weight loss group (no weight loss requirements)
Number of subjects: 100
Study: 15471363

Group type: EXPERIMENTAL
Intervention: Ibudilast (60 mg/day p.o. for four weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (healthy subjects or untreated MS patients)
Number of subjects: 0
Study: 11531934

Group type: EXPERIMENTAL
Intervention: 1alpha‐hydroxyvitamin D3 + sequential combined HRT + calcium supplement
Number of subjects: 240

Group type: COMPARATOR
Intervention: sequential combined HRT + calcium supplement
Number of subjects: 240
Study: 9762781

Group type: EXPERIMENTAL
Intervention: Protective respiratory device (RD) with a P2 filter
Number of subjects: 26

Group type: COMPARATOR
Intervention: No respiratory device (control)
Number of subjects: 26
Study: 8151382

Group type: EXPERIMENTAL
Intervention: Stress (ST) imaging
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Redistribution (RD) imaging
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Reinjection (RI) imaging
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Individual observer measurement of ST-RD
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Individual observer measurement of ST-RI
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Individual observer measurement of RD-RI
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Multiple observer scores for ST-RD
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Multiple observer scores for ST-RI
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Multiple observer scores for RD-RI
Number of subjects: 396
Study: 3071594

Group type: EXPERIMENTAL
Intervention: Stepped care (standardized intensive drug treatment)
Number of subjects: 10940

Group type: COMPARATOR
Intervention: Referred care (usual community care)
Number of subjects: 10940
Study: 30566030

Group type: EXPERIMENTAL
Intervention: Dalfampridine
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 29781109

Group type: EXPERIMENTAL
Intervention: In-hospital change in heart rate
Number of subjects: 7141

Group type: EXPERIMENTAL
Intervention: In-hospital change in systolic blood pressure (SBP)
Number of subjects: 7141

Group type: EXPERIMENTAL
Intervention: In-hospital change in rate pressure product (RPP)
Number of subjects: 7141

Group type: EXPERIMENTAL
Intervention: Baseline systolic blood pressure (SBP)
Number of subjects: 7141
Study: 26901263

Group type: EXPERIMENTAL
Intervention: LACE training (10-session DVD format)
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: LACE training (20-session computer-based format)
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Placebo auditory training (10 hours of digitized books listening)
Number of subjects: 279

Group type: COMPARATOR
Intervention: Educational counseling (control group)
Number of subjects: 279
Study: 24886626

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet supplemented with extra-virgin olive oil
Number of subjects: 7216

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet supplemented with total olive oil
Number of subjects: 7216

Group type: EXPERIMENTAL
Intervention: Higher baseline total olive oil consumption
Number of subjects: 7216

Group type: EXPERIMENTAL
Intervention: Extra-virgin olive oil consumption increase by 10 g/d
Number of subjects: 7216

Group type: COMPARATOR
Intervention: Control low-fat diet
Number of subjects: 7216
Study: 23296557

Group type: EXPERIMENTAL
Intervention: ALMI approach
Number of subjects: 47

Group type: COMPARATOR
Intervention: Bauer approach
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 47
Study: 20157326

Group type: EXPERIMENTAL
Intervention: LKF-enriched bread (lupin)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control (white bread)
Number of subjects: 88
Study: 18408580

Group type: EXPERIMENTAL
Intervention: Neoral C2 monitoring with high range (1600-1800 ng/mL)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Neoral C2 monitoring with intermediate range (1400-1600 ng/mL)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Neoral C2 monitoring with low range (1200-1400 ng/mL)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Intermediate C2 range in cohort B
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Neoral C2 monitoring (all groups)
Number of subjects: 87
Study: 15816467

Group type: EXPERIMENTAL
Intervention: Cimetidine (CIM) administered perioperatively, initiated 7 days before operation and continued until 10 days after surgery.
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no cimetidine treatment).
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Cimetidine (CIM) treatment.
Number of subjects: 49
Study: 12459936

Group type: EXPERIMENTAL
Intervention: Clodronate 800 mg daily
Number of subjects: 610

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Clodronate 400-800 mg
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Clodronate
Number of subjects: 610
Study: 10379611

Group type: EXPERIMENTAL
Intervention: Dorzolamide eye drops applied three times daily for 3 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo preparation applied according to the same protocol
Number of subjects: 30
Study: 8540451

Group type: EXPERIMENTAL
Intervention: Beta-blocker group (n = 58)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (n = 58)
Number of subjects: 116
Study: 1907662

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia (85 patients)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Epidural morphine (76 patients)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia
Number of subjects: 161

Group type: COMPARATOR
Intervention: Epidural morphine
Number of subjects: 161
Study: 6138120

Group type: EXPERIMENTAL
Intervention: Trimeprazine (sedative H1 antihistamine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nitrazepam (sedative benzodiazepine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Astemizole (non-sedative H1 antihistamine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Terfenadine (non-sedative H1 antihistamine)
Number of subjects: 0
Study: 30446849

Group type: EXPERIMENTAL
Intervention: MELD-Na score ≥ 10
Number of subjects: 48955

Group type: EXPERIMENTAL
Intervention: Incremental increases in MELD-Na score (10–14)
Number of subjects: 48955

Group type: EXPERIMENTAL
Intervention: Incremental increases in MELD-Na score (15–19)
Number of subjects: 48955

Group type: EXPERIMENTAL
Intervention: Incremental increases in MELD-Na score (≥ 20)
Number of subjects: 48955
Study: 28397649

Group type: EXPERIMENTAL
Intervention: New clinical protocol with referral pathway, training and support for paramedics.
Number of subjects: 2391

Group type: COMPARATOR
Intervention: Control group continued practice as normal.
Number of subjects: 2391
Study: 25637614

Group type: EXPERIMENTAL
Intervention: Directed Osteopathic Manipulative Treatment (D-OMT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nondirected Osteopathic Manipulative Treatment (ND-OMT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups (D-OMT, ND-OMT, Control)
Number of subjects: 0
Study: 24212451

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention program including supervised physical activity, structured nutrition education, dietary modification, and behavioral support over 6 months.
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention program
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Reduction in energy intake
Number of subjects: 145

Group type: COMPARATOR
Intervention: Physical activity
Number of subjects: 145
Study: 22473616

Group type: EXPERIMENTAL
Intervention: Vestibular stimulus presented before auditory stimulus (61 ms at 0.5 Hz, 19 ms at 1.0 Hz)
Number of subjects: 5
Study: 21054847

Group type: EXPERIMENTAL
Intervention: Joint Crisis Plan (JCP)
Number of subjects: 540

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 540
Study: 17931938

Group type: EXPERIMENTAL
Intervention: Proroot MTA mixed with water (group 1, n = 20)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Proroot MTA without hydration (group 2, n = 20)
Number of subjects: 44
Study: 15849222

Group type: EXPERIMENTAL
Intervention: Trastuzumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard chemotherapy (with or without trastuzumab)
Number of subjects: 0
Study: 12040975

Group type: EXPERIMENTAL
Intervention: Oral testosterone undecanoate for 2 months
Number of subjects: 86
Study: 9620507

Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA) - propofol, N2O, laryngeal mask airway
Number of subjects: 26

Group type: COMPARATOR
Intervention: Epidural Anesthesia (EPID) - lidocaine 1.5% with epinephrine
Number of subjects: 26
Study: 7703621

Group type: EXPERIMENTAL
Intervention: Ossein-hydroxyapatite (OHC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Calcium carbonate (CC)
Number of subjects: 40
Study: 3080622

Group type: EXPERIMENTAL
Intervention: Unbalanced amino acid solutions (essential amino acids, branched‐chain amino acids)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Balanced and complete amino acid solution
Number of subjects: 0
Study: 28177498

Group type: EXPERIMENTAL
Intervention: mTHS
Number of subjects: 160

Group type: COMPARATOR
Intervention: mCC
Number of subjects: 160

Group type: COMPARATOR
Intervention: SA
Number of subjects: 160
Study: 27813452

Group type: EXPERIMENTAL
Intervention: Computerized cognitive remediation
Number of subjects: 420

Group type: COMPARATOR
Intervention: Computer-based health education training
Number of subjects: 420
Study: 25483701

Group type: EXPERIMENTAL
Intervention: HPV-16/18 vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: HPV-6/11/16/18 vaccine
Number of subjects: 0
Study: 22152673

Group type: EXPERIMENTAL
Intervention: Computer Assessment of Simulated Patient Interviews (CASPI)
Number of subjects: 120
Study: 20462091

Group type: EXPERIMENTAL
Intervention: 2.5% phenylephrine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 10% phenylephrine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 100
Study: 18664777

Group type: EXPERIMENTAL
Intervention: PEEP (5‐8 cm H2O)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Control (no PEEP)
Number of subjects: 131
Study: 18389361

Group type: EXPERIMENTAL
Intervention: Sexually active heterosexual men
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Sexually active gay/bisexual men
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Sexually active heterosexual women
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Overall sexual activity
Number of subjects: 290
Study: 15179103

Group type: EXPERIMENTAL
Intervention: High intensity aerobic interval exercise (80-90% of VO2peak)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Moderate intensity exercise (50-60% of VO2peak)
Number of subjects: 21
Study: 11740265

Group type: EXPERIMENTAL
Intervention: DPL-CT
Number of subjects: 252

Group type: COMPARATOR
Intervention: CT
Number of subjects: 252
Study: 9863123

Group type: EXPERIMENTAL
Intervention: Tiaoxue Yisui recipe
Number of subjects: 78

Group type: COMPARATOR
Intervention: SSL regimen
Number of subjects: 78
Study: 8349939

Group type: EXPERIMENTAL
Intervention: Furosemide (40 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bumetanide (2 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2882868

Group type: EXPERIMENTAL
Intervention: Felodipine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31603024

Group type: EXPERIMENTAL
Intervention: Quick responding
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Slow responding
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Fast responding
Number of subjects: 1500
Study: 28987287

Group type: EXPERIMENTAL
Intervention: Potentially effective low-risk treatments for weight-loss devices
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Potentially less effective and riskier treatments for weight-loss devices
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimal RCT design for weight-loss devices
Number of subjects: 0
Study: 26781700

Group type: EXPERIMENTAL
Intervention: Ready-to-eat food product (Vita-Weat biscuit) as part of a diet prescription for weight loss
Number of subjects: 76

Group type: COMPARATOR
Intervention: Advice on the 'Australian Guide to Healthy Eating' (control group)
Number of subjects: 76
Study: 24552306

Group type: EXPERIMENTAL
Intervention: Intensified diagnostics (concentrated AFB smear and tuberculosis culture)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard diagnostics (direct AFB smear only)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Antituberculosis therapy
Number of subjects: 70
Study: 22367487

Group type: EXPERIMENTAL
Intervention: Choline-supplemented diet (T(3))
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Betaine-supplemented diet (T(4))
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Lecithin-supplemented diet (T(5))
Number of subjects: 270

Group type: COMPARATOR
Intervention: Control diet (T(0))
Number of subjects: 270

Group type: COMPARATOR
Intervention: Control diet with endosulfan (T(1))
Number of subjects: 270

Group type: COMPARATOR
Intervention: Control diet with endosulfan and elevated temperature (T(2))
Number of subjects: 270
Study: 20869326

Group type: EXPERIMENTAL
Intervention: Total disc arthroplasty (TDA)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Anterior cervical discectomy and fusion (ACDF)
Number of subjects: 93
Study: 17998837

Group type: EXPERIMENTAL
Intervention: E. coli Nissle (Mutaflor)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 15353421

Group type: EXPERIMENTAL
Intervention: Telephone interviews
Number of subjects: 1270

Group type: COMPARATOR
Intervention: Mailed questionnaires
Number of subjects: 1270

Group type: EXPERIMENTAL
Intervention: Cost of telephone interviews
Number of subjects: 1270

Group type: COMPARATOR
Intervention: Cost of mailed questionnaires
Number of subjects: 1270
Study: 12439366

Group type: EXPERIMENTAL
Intervention: Fenoldopam mesylate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9855212

Group type: EXPERIMENTAL
Intervention: Distension combined with steroid
Number of subjects: 20

Group type: COMPARATOR
Intervention: Steroid alone
Number of subjects: 20
Study: 7989481

Group type: EXPERIMENTAL
Intervention: Preoperative plasma prorenin and renin concentrations measured in children with nephroblastoma
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Increase in plasma prorenin concentration
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Nephroblastoma tissue analysis
Number of subjects: 25
Study: 2651106

Group type: EXPERIMENTAL
Intervention: Sodium acetate infusion at 2.5 mmoles/min for 60 min
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sodium bicarbonate infusion (control)
Number of subjects: 12
Study: 29090685

Group type: EXPERIMENTAL
Intervention: Tocilizumab (8 mg/kg, 3 monthly infusions)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 36
Study: 28463714

Group type: EXPERIMENTAL
Intervention: Two-stage integrated care (IC)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Antipsychotic medication-alone
Number of subjects: 170
Study: 26323969

Group type: EXPERIMENTAL
Intervention: Gamma Delta Tocotrienol (GDT) - 2 capsules of 300 mg (450 mg γ‐T3 and 150 mg δ‐T3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tocotrienol-Rich Fraction (TRF) - 4 capsules of 200 mg (451.2 mg γ‐T3 & 102.72 mg δ‐T3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GDT and TRF
Number of subjects: 0
Study: 24548399

Group type: EXPERIMENTAL
Intervention: recombinant tissue plasminogen activator (rt‐PA) and parental anticoagulant
Number of subjects: 90

Group type: COMPARATOR
Intervention: parental anticoagulation
Number of subjects: 90
Study: 22027736

Group type: EXPERIMENTAL
Intervention: DEB SeQuent Please
Number of subjects: 84

Group type: COMPARATOR
Intervention: DES Taxus Liberté
Number of subjects: 84
Study: 18303156

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (1 mg, 0.04 ml)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Photodynamic therapy (PDT) plus intravitreal triamcinolone (4 mg)
Number of subjects: 28
Study: 16529689

Group type: EXPERIMENTAL
Intervention: Thread-dragging through fistula method
Number of subjects: 244

Group type: COMPARATOR
Intervention: Control group (incision or thread-drawing)
Number of subjects: 244
Study: 12419013

Group type: EXPERIMENTAL
Intervention: Anonymity of in-group members to the self
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Anonymity of the self to the group
Number of subjects: 2
Study: 10352330

Group type: EXPERIMENTAL
Intervention: G‐CSF
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control (historical controls without G‐CSF)
Number of subjects: 132
Study: 7856699

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 2947

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2947
Study: 2044736

Group type: EXPERIMENTAL
Intervention: Vitamin E 25 units
Number of subjects: 268

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 268